Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
791.50    1.50 (0.19%)
Bid:
792.00
Ask:
795.00
Spread: 3.00 (0.379%)
Market Cap: £911.60m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Director/PDMR Shareholding

12 Aug 2021 14:05

RNS Number : 4900I
Kainos Group plc
12 August 2021
 

12 August 2021

Kainos Group plc

("Kainos" or the "Company")

 

Director / PDMR shareholdings

The Company was notified on 11 August 2021, that Paul Gannon, Director, sold 200,000 ordinary shares in the Company at an aggregated price of £18.01 per ordinary share.

The Company was further notified on 11 August 2021, that Mr Gannon exercised his 2017 PSP options over 19,346 ordinary shares of £0.005 in the Company and his 2018 PSP options over 15,690 ordinary shares of £0.005 in the Company, both at an exercise price of £0.005 per ordinary share.

Mr Gannon retained the ordinary shares on exercise.

Following this notification, Mr Gannon and his Person Closely Associated (PCA) have a reportable shareholding of 7,164,044 ordinary shares in the issued share capital of the Company, constituting 5.81% of the issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Paul Gannon

2.

Reason for the notification

a.

Position/status

Director

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of £0.005 each

 

 

KNOS

b.

Nature of the transaction

Sale of Shares & Exercise of Options

c.

Price(s) and volume(s)

Price(s)

Volume(s)

£18.01

200,000

£0.005

19,346

£0.005

15,690

 

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

11-August-2021

f.

Place of the transaction

LSE - Regulated Market - XLON

 

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47 

 

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Ben Griffiths

 

Canaccord Genuity +44 20 7523 4606

Simon Bridges/ Andrew Potts

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Dwight Burden / Kwaku Aning

 

 

 

About Kainos

Kainos Group plc is a UK-headquartered IT provider, across two specialist business areas, Digital Services and the Workday Practice.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for public sector, healthcare and commercial customers. These transformative solutions encompass a range of services from experience design to artificial intelligence and cloud to deliver truly intelligent solutions that are secure, accessible and cost-effective.

The Group's Workday Practice is one of Workday's most respected partners. As a full-service partner, we are experienced in complex deployment and integrations, and the leader in Workday test automation.

We're trusted by our customers to launch, test, expand and safeguard their Workday systems. Kainos has over 2,000 people across 12 offices in Europe and North America. Kainos is listed on the London Stock Exchange (LSE: KNOS).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKBBPBBKDAFD
Date   Source Headline
19th Aug 201912:02 pmRNSPrice Monitoring Extension
2nd Aug 20194:52 pmRNSHolding(s) in Company
1st Aug 20192:35 pmRNSTotal Voting Rights
31st Jul 201911:30 amRNSAnnual Report 2019
26th Jul 201911:36 amRNSHolding(s) in Company
24th Jul 20197:00 amRNSBoard Change
18th Jul 201912:02 pmRNSPrice Monitoring Extension
8th Jul 20191:24 pmRNSDirector/PDMR Shareholding
4th Jul 20193:10 pmRNSHolding(s) in Company
1st Jul 20192:09 pmRNSTotal Voting Rights
25th Jun 20198:33 amRNSHolding(s) in Company
24th Jun 20191:43 pmRNSHolding(s) in Company
17th Jun 20194:40 pmRNSHolding(s) in Company
17th Jun 20194:26 pmRNSDirector/PDMR Shareholding
31st May 20194:06 pmRNSTotal Voting Rights
29th May 20197:55 amRNSHolding(s) in Company
29th May 20197:44 amRNSHolding(s) in Company
28th May 20197:00 amRNSPreliminary Results
1st May 20196:10 pmRNSTotal Voting Rights
1st May 20196:10 pmRNSBlock listing Interim Review
16th Apr 20197:00 amRNSTrading Statement
1st Apr 20193:29 pmRNSTotal Voting Rights
21st Mar 20194:28 pmRNSHolding(s) in Company
7th Mar 201911:31 amRNSDirector/PDMR Shareholding
28th Feb 201912:11 pmRNSTotal Voting Rights
25th Feb 20194:47 pmRNSHolding(s) in Company
12th Feb 20197:00 amRNSKainos announces site purchase for new Belfast HQ
6th Feb 20195:11 pmRNSAdmission of Shares to Trading
6th Feb 20193:59 pmRNSHolding(s) in Company
5th Feb 20194:01 pmRNSHolding(s) in Company
4th Feb 20194:11 pmRNSTotal Voting Rights
4th Feb 20197:00 amRNSTrading Update
6th Dec 20184:35 pmRNSPrice Monitoring Extension
5th Dec 20181:02 pmRNSDirector/PDMR Shareholding
3rd Dec 20181:38 pmRNSTotal Voting Rights
26th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSInterim Results
23rd Nov 20184:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20184:35 pmRNSPrice Monitoring Extension
12th Nov 20184:35 pmRNSPrice Monitoring Extension
2nd Nov 20185:02 pmRNSHolding(s) in Company
1st Nov 20183:57 pmRNSAdmission of Shares to Trading
1st Nov 20183:53 pmRNSBlock Admission
1st Nov 20183:49 pmRNSTotal Voting Rights
18th Oct 201812:07 pmRNSSecond Price Monitoring Extn
18th Oct 201812:02 pmRNSPrice Monitoring Extension
3rd Oct 20187:00 amRNSChange of Registered Office
1st Oct 20184:47 pmRNSTotal Voting Rights
20th Sep 20183:15 pmRNSAGM Statement
14th Sep 20184:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.